William J. Sandborn, M.D., is a world-renowned clinician, entrepreneur, executive and advisor in the biopharmaceutical industry.

He previously served the President and Chief Medical Officer of Ventyx Biosciences, Inc. Dr. Sandborn co-founded Santarus, Inc. in 1999 and Shoreline Biosciences, Inc. in 2020, and served as the CMO of Shoreline from 2021 through 2022. He served as a professor of medicine and chief of the Division of Gastroenterology at University of California, San Diego – School of Medicine from January 2011 to April 2021. Prior to UCSD, Dr. Sandborn was a professor of medicine and Vice Chair, Division of Gastroenterology and Hepatology, from March 1993 to December 2010. Dr. Sandborn has published over 956 peer reviewed articles including articles in the New England Journal of Medicine, Nature, Lancet, JAMA, Annals of Internal Medicine, and Gastroenterology. In 2019, he was awarded the Sherman Prize for his work in inflammatory bowel disease.

Dr. Sandborn holds a B.A. in Chemistry from Southern College and completed medical school and an internal medicine residency at Loma Linda University. He completed a gastroenterology fellowship at the Mayo Clinic in Rochester, Minnesota.